Paul Sauer, SVP Process Development, Manufacturing at Vaxcyte, Inc. (PCVX), sold 3,000 shares at $26.22 ($79K) on 2022-05-23, disclosed to the SEC on 2022-05-25.
Open-market sale of $79k PCVX by SVP Process Development, Manufacturing. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| PCVX | SELL | 2022-07-22 | $75K | — | Filing → |
| PCVX | SELL | 2022-04-26 | $75K | — | Filing → |
| PCVX | SELL | 2022-03-24 | $75K | — | Filing → |